L'intérêt à découvert pour Applied Therapeutics donne aux investisseurs une idée du degré auquel les investisseurs parient sur la baisse de l'action de Applied Therapeutics. Les données sur l'intérêt à découvert sont mises à jour toutes les deux semaines.

Applied Therapeutics (NASDAQ:APLT) Stock, Rapport sur les intérêts à découvert

Applied Therapeutics

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

Applied Therapeutics, Inc. - Common Stock

Applied Therapeutics Inc

Fortnite's Chapter 6 trailer leaked early, giving players a first look at the game's latest update before its official <a href="https://www.benzinga.com/general/gaming">release this weekend. </a>
While the official launch isn't slated until after Saturday's Remix live event featuring <a href="https://www.benzinga.com/general/gaming/23/11/35922646/eminem-joins-fortnites-big-bang-event-exclusive-slim-shady-skins-and-a-virtual-concert">Eminem </a>and <a href="https://www.benzinga.com/topic/snoop-dogg">Snoop Dogg</a>, this accidental in-game release has already sent the community into a frenzy, Eurogamer <a href="https://www.eurogamer.net/fortnite-chapter-6-launch-trailer-goes-live-early-reveals-roaming-godzilla-and-giant-turtle">reported.</a>
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">CHAPTER 6 LAUNCH TRAILER!! &#x1f525; (via <a href="https://twitter.com/Guille_GAG?ref_src=twsrc%5Etfw">@Guille_GAG</a>)<a href="https://t.co/FTPCjtW2H9">pic.twitter.com/FTPCjtW2H9</a>
&mdash; Shiina (@ShiinaBR) <a href="https://twitter.com/ShiinaBR/status/1862454298765934945?ref_src=twsrc%5Etfw">November 29, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
<h1 class="wp-block-heading">Godzilla Headlines New Boss Battles</h1>
The trailer confirms Godzilla will roam the game's new Japan-inspired map as a massive boss encounter. Alongside the iconic kaiju, players can expect to face other bosses, including a giant samurai, a floating demon mask and a massive turtle.
See Also: <a href="https://www.benzinga.com/news/legal/24/11/42229617/microsofts-xbox-game-store-for-android-ready-to-go-live-says-executive-but-legal-standoff-with-google-halts-launch">Microsoft&#8217;s Xbox Game Store For Android &#8216;Ready To Go Live,&#8217; Says Executive, But Legal Standoff With Google Halts Launch</a>
<h1 class="wp-block-heading">Pets, Weapons, And Baymax</h1>
Epic Games&#8217; online video game is also introducing pet-like creatures, with the trailer showing jelly-like companions and small dragons perched on characters' shoulders. 
Samurai swords make a return, appearing similar to those seen in previous seasons, while Big Hero 6's Baymax is joining the Chapter 6 Season 1 battle pass, complete with his "Balalala" emote.
<h1 class="wp-block-heading">Familiar Features In A New Setting</h1>
While the map brings fresh designs, some elements will feel familiar to long-time players, such as Japanese-inspired architecture reminiscent of Chapter 4's biome. 
Godzilla's appearance also draws comparisons to past live events like Doctor Doom's towering presence, though this time players will face fire breath instead of sorcery.
Chapter 6 officially launches next week, followed by the arrival of Fortnite OG mode, which brings back the game's original map as a permanent option with its own battle pass.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/11/42222962/ps-plus-december-lineup-new-games-exclusive-trials-30th-anniversary-surprises">PS Plus December Lineup: New Games, Exclusive Trials And 30th Anniversary Surprises</a></li>
</ul>
Photo: Shutterstock.

Gaming

News

General

Fortnite Chapter 6 Trailer Leaks Early, Here's What's Coming

Financial giants have made a conspicuous bearish move on Bloom Energy. Our analysis of options history for Bloom Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>) revealed 16 unusual trades.
Delving into the details, we found 12% of traders were bullish, while 75% showed bearish tendencies. Out of all the trades we spotted, 2 were puts, with a value of $100,400, and 14 were calls, valued at $716,187.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $27.0 to $35.0 for Bloom Energy over the last 3 months. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Bloom Energy's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Bloom Energy's whale activity within a strike price range from $27.0 to $35.0 in the last 30 days. 
<h3>Bloom Energy Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732902349_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>BE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$5.4</td>
<td>$5.3</td>
<td>$5.3</td>
<td>$31.00</td>
<td>$102.2K</td>
<td>0</td>
<td align="right">193</td>
</tr>
<tr>
<td>BE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$4.4</td>
<td>$4.3</td>
<td>$4.3</td>
<td>$33.00</td>
<td>$92.0K</td>
<td>10</td>
<td align="right">214</td>
</tr>
<tr>
<td>BE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$1.1</td>
<td>$1.05</td>
<td>$1.05</td>
<td>$30.00</td>
<td>$78.7K</td>
<td>1.1K</td>
<td align="right">750</td>
</tr>
<tr>
<td>BE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$3.8</td>
<td>$3.6</td>
<td>$3.65</td>
<td>$35.00</td>
<td>$73.0K</td>
<td>1.2K</td>
<td align="right">402</td>
</tr>
<tr>
<td>BE</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$3.8</td>
<td>$3.6</td>
<td>$3.62</td>
<td>$35.00</td>
<td>$72.6K</td>
<td>1.2K</td>
<td align="right">602</td>
</tr>
</tbody>
</table>

<h3>About Bloom Energy</h3>
Bloom Energy designs, manufactures, sells, and installs solid-oxide fuel cell systems ("Energy Servers") for on-site power generation. Bloom Energy Servers are fuel-flexible and can use natural gas, biogas, and hydrogen to create 24/7 electricity for stationary applications. In 2021, the company announced plans to leverage its technology and enter the electrolyzer market. Bloom primarily sells its systems in the United States and internationally.
<h3>Where Is Bloom Energy Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 2,532,953, the BE's price is up by 1.91%, now at $27.73. </li>
<li>RSI readings suggest the stock is currently may be overbought.</li>
<li>Anticipated earnings release is in 76 days.</li>
</ul>
<h3>Expert Opinions on Bloom Energy</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $20.6.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from RBC Capital keeps a Outperform rating on Bloom Energy with a target price of $28. 
&#x2A; An analyst from Morgan Stanley has decided to maintain their Overweight rating on Bloom Energy, which currently sits at a price target of $28. 
&#x2A; Consistent in their evaluation, an analyst from BTIG keeps a Buy rating on Bloom Energy with a target price of $20. 
&#x2A; In a positive move, an analyst from Piper Sandler has upgraded their rating to Overweight and adjusted the price target to $20. 
&#x2A; Maintaining their stance, an analyst from B of A Securities continues to hold a Underperform rating for Bloom Energy, targeting a price of $7. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Bloom Energy, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Markets

Bloom Energy's Options Frenzy: What You Need to Know

Investors with a lot of money to spend have taken a bullish stance on Delta Air Lines (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DAL#NYSE">DAL</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with DAL, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 13 uncommon options trades for Delta Air Lines.
This isn't normal.
The overall sentiment of these big-money traders is split between 46% bullish and 38%, bearish.
Out of all of the special options we uncovered, 2 are puts, for a total amount of $94,621, and 11 are calls, for a total amount of $1,558,545.
<h3>Expected Price Movements</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $45.0 to $85.0 for Delta Air Lines over the recent three months. 
<h3>Volume &amp; Open Interest Trends</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Delta Air Lines's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Delta Air Lines's whale trades within a strike price range from $45.0 to $85.0 in the last 30 days. 
<h3>Delta Air Lines Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732902344_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>DAL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$17.55</td>
<td>$17.5</td>
<td>$17.5</td>
<td>$47.00</td>
<td>$348.2K</td>
<td>11.7K</td>
<td align="right">199</td>
</tr>
<tr>
<td>DAL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/06/24</td>
<td>$17.0</td>
<td>$16.8</td>
<td>$17.0</td>
<td>$47.00</td>
<td>$338.2K</td>
<td>18</td>
<td align="right">199</td>
</tr>
<tr>
<td>DAL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/06/24</td>
<td>$17.1</td>
<td>$16.9</td>
<td>$16.9</td>
<td>$47.00</td>
<td>$336.3K</td>
<td>18</td>
<td align="right">199</td>
</tr>
<tr>
<td>DAL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/19/25</td>
<td>$8.0</td>
<td>$7.8</td>
<td>$7.8</td>
<td>$70.00</td>
<td>$156.0K</td>
<td>730</td>
<td align="right">200</td>
</tr>
<tr>
<td>DAL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>12/19/25</td>
<td>$7.0</td>
<td>$6.9</td>
<td>$6.9</td>
<td>$72.50</td>
<td>$138.0K</td>
<td>64</td>
<td align="right">200</td>
</tr>
</tbody>
</table>

<h3>About Delta Air Lines</h3>
Atlanta-based Delta Air Lines is one of the world's largest airlines, with a network of over 300 destinations in more than 50 countries. Delta operates a hub-and-spoke network, where it gathers and distributes passengers across the globe through its biggest hubs in Atlanta, New York, Salt Lake City, Detroit, Seattle, and Minneapolis-St. Paul. Delta has historically earned most of its international revenue and profits from flying passengers over the Atlantic Ocean.
After a thorough review of the options trading surrounding Delta Air Lines, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Present Market Standing of Delta Air Lines</h3>
<ul>
<li>With a trading volume of 1,470,817, the price of DAL is up by 0.44%, reaching $63.9.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 42 days from now.</li>
</ul>
<h3>What The Experts Say On Delta Air Lines</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $80.2.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from Citigroup continues to hold a Buy rating for Delta Air Lines, targeting a price of $76. 
&#x2A; An analyst from Jefferies persists with their Buy rating on Delta Air Lines, maintaining a target price of $72. 
&#x2A; In a cautious move, an analyst from UBS downgraded its rating to Buy, setting a price target of $88. 
&#x2A; An analyst from Barclays persists with their Overweight rating on Delta Air Lines, maintaining a target price of $90. 
&#x2A; An analyst from TD Cowen has decided to maintain their Buy rating on Delta Air Lines, which currently sits at a price target of $75. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Delta Air Lines with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

Market Whales and Their Recent Bets on DAL Options

Investors with a lot of money to spend have taken a bullish stance on Arista Networks (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANET#NYSE">ANET</a>).
And retail traders should know.
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with ANET, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 18 options trades for Arista Networks.
This isn't normal.
The overall sentiment of these big-money traders is split between 44% bullish and 44%, bearish.
Out of all of the options we uncovered, there was 1 put, for a total amount of $35,401, and 17, calls, for a total amount of $935,838.
<h3>Expected Price Movements</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $310.0 and $500.0 for Arista Networks, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Arista Networks stands at 236.17, with a total volume reaching 469.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Arista Networks, situated within the strike price corridor from $310.0 to $500.0, throughout the last 30 days.
<h3>Arista Networks Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732902339_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ANET</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$64.3</td>
<td>$62.2</td>
<td>$64.3</td>
<td>$410.00</td>
<td>$160.7K</td>
<td align="right">70</td>
<td align="right">25</td>
</tr>
<tr>
<td>ANET</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/29/24</td>
<td>$10.7</td>
<td>$8.1</td>
<td>$9.75</td>
<td>$395.00</td>
<td>$144.9K</td>
<td align="right">207</td>
<td align="right">166</td>
</tr>
<tr>
<td>ANET</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/29/24</td>
<td>$7.0</td>
<td>$6.9</td>
<td>$7.0</td>
<td>$400.00</td>
<td>$74.2K</td>
<td align="right">322</td>
<td align="right">135</td>
</tr>
<tr>
<td>ANET</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/06/24</td>
<td>$38.3</td>
<td>$35.5</td>
<td>$36.26</td>
<td>$370.00</td>
<td>$72.5K</td>
<td align="right">80</td>
<td align="right">22</td>
</tr>
<tr>
<td>ANET</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$123.5</td>
<td>$122.6</td>
<td>$123.5</td>
<td>$310.00</td>
<td>$61.7K</td>
<td align="right">6</td>
<td align="right">5</td>
</tr>
</tbody>
</table>

<h3>About Arista Networks</h3>
Arista Networks is a networking equipment provider that primarily sells Ethernet switches and software to data centers. Its marquee product is its extensible operating system, or EOS, that runs a single image across every single one of its devices. The firm operates as one reportable segment. It has steadily gained market share since its founding in 2004, with a focus on high-speed applications. Arista counts Microsoft and Meta Platforms as its largest customers and derives roughly three quarters of its sales from North America.
In light of the recent options history for Arista Networks, it's now appropriate to focus on the company itself. We aim to explore its current performance.
<h3>Present Market Standing of Arista Networks</h3>
<ul>
<li>With a volume of 793,223, the price of ANET is up 0.52% at $404.39. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 73 days.</li>
</ul>
<h3>Expert Opinions on Arista Networks</h3>
In the last month, 4 experts released ratings on this stock with an average target price of $415.25.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from UBS has decided to maintain their Neutral rating on Arista Networks, which currently sits at a price target of $425. 
&#x2A; An analyst from Piper Sandler has revised its rating downward to Neutral, adjusting the price target to $421. 
&#x2A; An analyst from Rosenblatt has decided to maintain their Sell rating on Arista Networks, which currently sits at a price target of $320. 
&#x2A; Consistent in their evaluation, an analyst from Barclays keeps a Overweight rating on Arista Networks with a target price of $495. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Arista Networks with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.

ANET

Smart Money Is Betting Big In ANET Options

Mark Cuban, the outspoken billionaire entrepreneur, has a clear message, which he shared in a 2022 CNBC interview: <a href="https://www.benzinga.com/personal-finance/24/05/39092288/if-you-use-your-credit-card-you-do-not-want-to-be-rich-warns-mark-cuban-on-the-dave-ramsey-show">"Credit cards are not your friend."</a>
Cuban argues that relying on credit cards can lead to <a href="https://www.benzinga.com/personal-finance/24/09/40985018/mark-cubans-black-amex-card-was-declined-trying-to-buy-a-140-000-bottle-of-champagne-after-his-n">serious financial pitfalls</a>, largely due to their notoriously high interest rates. As an alternative, he suggests that personal loans might be a better option for managing expenses. But is this advice universally applicable?
Don't Miss:
<ul>
<li>Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.</li>
<li>The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?</li>
</ul>
Cuban's primary concern with credit cards is their steep interest rates. As of November 2024, the average credit card interest rate stood at 24.62%, with some cards charging as much as 36%, according to WalletHub.&nbsp;
Balancing can quickly become costly, making it challenging to pay off debt. Cuban emphasizes that the compounding interest can be financially draining unless you can pay your balance in full each month.
In a 2014 appearance on the Dave Ramsey Show, Cuban explained, &#8220;The best place to invest is to pay off all your credit cards and burn them.&#8221; He further stated, &#8220;If you pay 15 or 20 percent interest and pay that down … you just earned 15 or 20 percent."
See Also: The global games market is projected to generate $272B by the end of the year —<a href="https://www.benzinga.com/money/gameflip"> for $0.55/share, this VC-backed startup with a 7M+ userbase gives investors easy access to this asset market.</a>
In contrast, personal loans often come with lower interest rates. For <a href="https://www.benzinga.com/personal-finance/24/09/40920706/billionaire-mark-cuban-says-his-credit-was-so-bad-radio-shack-denied-him-if-you-use-credit-cards">borrowers with good credit</a> scores between 690 and 719, the average personal loan interest rate is approximately 14.35%. Cuban points out that personal loans can provide the necessary funds at a more affordable rate for those with a solid credit history while still contributing to building credit.
Personal loans also offer structured repayment plans, typically with fixed monthly payments over a set term. This structure can make budgeting more predictable and help borrowers avoid the revolving debt cycle that credit cards can perpetuate.
While Cuban's perspective highlights the drawbacks of credit cards, other financial experts note that, when used responsibly, credit cards can offer significant benefits. They can be instrumental in building credit history, which is crucial for securing favorable terms on mortgages and auto loans.&nbsp;
Trending: Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die."<a href="https://www.benzinga.com/money/warren-buffet-make-money-when-you-sleep"> Here&#8217;s how you can earn passive income with just $100.</a>
Many credit cards provide rewards programs, purchase protections and other perks that personal loans do not offer.
Ted Rossman, a senior industry analyst at Bankrate.com, suggests to CNBC that personal loans are more appropriate for one-time necessary expenses, such as home improvements or consolidating high-interest debt. He cautions against using personal loans for discretionary spending, which can lead to further financial strain.
It's essential to recognize that credit cards and personal loans have their place in personal finance. The key is to understand your financial habits and needs:
<ul>
<li>For Everyday Expenses, a credit card can be beneficial. It offers rewards and helps build credit if you can pay off your balance in full each month.</li>
<li>A personal loan might be more suitable for larger One-Time Expenses, especially if it offers a lower interest rate and a structured repayment plan.</li>
</ul>
Ultimately, the decision between using a credit card or a personal loan should be based on your financial situation, spending habits and ability to manage debt responsibly. Cuban's advice highlights the potential dangers of credit card debt, but you'll want to consider all factors and choose the best option<a href="https://www.benzinga.com/money/can-you-guess-how-many-americans-successfully-retire-with-1-million-saved"> with your financial goals</a>.
Read Next:
<ul>
<li>Studies show 50% of consumers think Financial Advisors cost much more than they do —<a href="https://www.benzinga.com/money/money-pickle"> to debunk this, this company provides matching for free and a complimentary first call with the matched advisor.</a></li>
<li>Many are using this retirement income calculator to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on what&#8217;s behind this formula.</a></li>
</ul>

Personal Finance

Mark Cuban Insists 'Credit Cards Are Not Your Friend' And Proposes Taking Out A Personal Loan For Expenses Instead – Is This A Smart Move?

GLJ Research analyst Gordon Johnson reiterates SolarEdge Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEDG#NASDAQ">SEDG</a>) with a Sell and maintains $3.9 price target.

Price Target

Reiteration

Analyst Ratings

SEDG

GLJ Research Reiterates Sell on SolarEdge Technologies, Maintains $3.9 Price Target

<a href="https://www.trade.gov/commerce-initiates-antidumping-and-countervailing-duty-investigations-crystalline-silicon" title="https://www.trade.gov/commerce-initiates-antidumping-and-countervailing-duty-investigations-crystalline-silicon">https://www.trade.gov/commerce-initiates-antidumping-and-countervailing-duty-investigations-crystalline-silicon</a>

Macro Economic Events

Legal

Global

Economics

ARRY

FSLR

NOVA

SHLS

iShares MSCI Thailand Investable Market Index Fund

U.S. Commerce Dept Sets Preliminary Antidumping Tariff Rate Of 125.37% On Solar Cells From Cambodia; Antidumping Tariff Rate Of 81.22% On Solar Cells From Malaysia; Antidumping Tariff Rate Of 70.36% On Solar Cells From Thailand; Antidumping Tariff Rate Of 271.28% On Solar Cells From Vietnam

Bristol-Myers Squibb Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>) filed a lawsuit on Tuesday against the U.S. Health Resources and Services Administration (HRSA) and the U.S. Department of Health and Human Services (HHS), alleging that HRSA's rejection of its proposed rebate model for the 340B Drug Pricing Program violates federal law.
Recently, Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>) filed a lawsuit against a U.S. government agency over a contentious&nbsp;<a target="_blank" href="https://www.benzinga.com/general/biotech/24/11/41941391/johnson-johnson-challenges-government-drug-pricing-dispute-over-two-drugs" rel="noreferrer noopener">disagreement about payment methods</a>.
The pharmaceutical giant contends the statute governing the program allows manufacturers to choose between rebate and discount pricing models and claims HRSA's decision undermines this flexibility.
The 340B Drug Pricing Program requires drug manufacturers to sell medications at reduced prices to eligible healthcare providers, known as "covered entities," under specific conditions.
Bristol-Myers has historically used the discount model, offering upfront price reductions. However, the company argues this approach has led to widespread program abuses, including violations of safeguards meant to prevent duplication with Medicaid Drug Rebate Program rebates and diversion of discounted drugs to ineligible recipients.
Bristol-Myers <a href="https://www.statnews.com/wp-content/uploads/2024/11/bristol-vs-hhs-hrsa-340b.pdf" target="_blank" rel="noreferrer noopener">claims</a> these issues are exacerbated by intermediaries such as commercial pharmacies and third-party administrators, who profit from price disparities.
Citing these abuses and insufficient enforcement by HHS, Bristol-Myers announced its intention in October 2024 to transition to a rebate model.
Under this system, covered entities would initially pay the commercial price and later receive a rebate to achieve the 340B price. Bristol-Myers argues this model, explicitly permitted by the 340B statute, would enhance program integrity by reducing opportunities for abuse.
Despite the statutory basis for both models, HRSA determined that Bristol-Myers' proposed shift to a rebate model was inconsistent with the 340B statute and required pre-approval.
Bristol-Myers asserts this decision unlawfully restricts manufacturers' statutory options, violates the Administrative Procedure Act, and represents arbitrary and capricious regulatory overreach.
The company further claims the decision is illogical and contradicts substantive due process principles by imposing irrational constraints.
Eli Lilly And Co.&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) has also filed a lawsuit against the HRSA. The pharmaceutical giant claims that HRSA obstructed its attempt to alter drug discount <a href="https://www.benzinga.com/general/biotech/24/11/42002487/mounjaro-maker-eli-lilly-files-lawsuit-against-us-agency-over-drug-rebate-program" target="_blank" rel="noreferrer noopener">offerings to hospitals</a>.
BMY Price Action: Bristol-Myers Squibb stock is up 0.12% at $59.36 at publication Friday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/11/42246190/whats-going-on-with-hub-cyber-security-stock-today" target="_blank" rel="noreferrer noopener">Hub Cyber Security Powers Up: Major Debt Reduction, Fresh Investment, Board Change &amp; More</a></li>
</ul>

Biotech

Government

Large Cap

Health Care

Bristol-Myers Squibb Files Lawsuit Against US Agency For Overreach In 340B Drug Pricing Program

WIIM

GRFS

Grifols shares are trading lower after the company ended discussions with Brookfield Capital Partners regarding a potential acquisition.

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. 
Below are some instances of options activity happening in the Health Care sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>MDT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/06/24</td>
<td>$86.00</td>
<td>$29.5K</td>
<td>72</td>
<td align="right">680</td>
</tr>
<tr>
<td>GEHC</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>12/06/24</td>
<td>$84.00</td>
<td>$41.1K</td>
<td>24</td>
<td align="right">368</td>
</tr>
<tr>
<td>IBRX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>05/16/25</td>
<td>$4.50</td>
<td>$25.0K</td>
<td>635</td>
<td align="right">330</td>
</tr>
<tr>
<td>LLY</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$720.00</td>
<td>$227.0K</td>
<td>99</td>
<td align="right">293</td>
</tr>
<tr>
<td>HIMS</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>11/29/24</td>
<td>$26.00</td>
<td>$94.8K</td>
<td>2.4K</td>
<td align="right">168</td>
</tr>
<tr>
<td>BSX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$75.00</td>
<td>$259.5K</td>
<td>533</td>
<td align="right">150</td>
</tr>
<tr>
<td>APLT</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$5.00</td>
<td>$33.0K</td>
<td>6.4K</td>
<td align="right">135</td>
</tr>
<tr>
<td>HROW</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$50.00</td>
<td>$31.9K</td>
<td>776</td>
<td align="right">118</td>
</tr>
<tr>
<td>DHR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$240.00</td>
<td>$55.0K</td>
<td>491</td>
<td align="right">114</td>
</tr>
<tr>
<td>PSTX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$5.00</td>
<td>$44.2K</td>
<td>85</td>
<td align="right">110</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These bullet-by-bullet explanations have been constructed using the accompanying table. 
• Regarding MDT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MDT#NYSE">MDT</a>), we observe a put option sweep with bearish sentiment. It expires in 7 day(s) on December 6, 2024. Parties traded 674 contract(s) at a $86.00 strike. This particular put needed to be split into 44 different trades to become filled. The total cost received by the writing party (or parties) was $29.5K, with a price of $44.0 per contract. There were 72 open contracts at this strike prior to today, and today 680 contract(s) were bought and sold. 
• Regarding GEHC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEHC#NASDAQ">GEHC</a>), we observe a put option sweep with neutral sentiment. It expires in 7 day(s) on December 6, 2024. Parties traded 360 contract(s) at a $84.00 strike. This particular put needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $41.1K, with a price of $113.0 per contract. There were 24 open contracts at this strike prior to today, and today 368 contract(s) were bought and sold. 
• Regarding IBRX (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBRX#NASDAQ">IBRX</a>), we observe a put option sweep with neutral sentiment. It expires in 168 day(s) on May 16, 2025. Parties traded 260 contract(s) at a $4.50 strike. This particular put needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $25.0K, with a price of $95.0 per contract. There were 635 open contracts at this strike prior to today, and today 330 contract(s) were bought and sold. 
• Regarding LLY (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>), we observe a put option trade with bullish sentiment. It expires in 112 day(s) on March 21, 2025. Parties traded 100 contract(s) at a $720.00 strike. The total cost received by the writing party (or parties) was $227.0K, with a price of $2270.0 per contract. There were 99 open contracts at this strike prior to today, and today 293 contract(s) were bought and sold. 
• For HIMS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>), we notice a call option sweep that happens to be bearish, is expiring today. Parties traded 158 contract(s) at a $26.00 strike. This particular call needed to be split into 8 different trades to become filled. The total cost received by the writing party (or parties) was $94.8K, with a price of $600.0 per contract. There were 2480 open contracts at this strike prior to today, and today 168 contract(s) were bought and sold. 
• Regarding BSX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>), we observe a call option sweep with bullish sentiment. It expires in 84 day(s) on February 21, 2025. Parties traded 150 contract(s) at a $75.00 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $259.5K, with a price of $1730.0 per contract. There were 533 open contracts at this strike prior to today, and today 150 contract(s) were bought and sold. 
• Regarding APLT (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLT#NASDAQ">APLT</a>), we observe a put option trade with bearish sentiment. It expires in 49 day(s) on January 17, 2025. Parties traded 110 contract(s) at a $5.00 strike. The total cost received by the writing party (or parties) was $33.0K, with a price of $300.0 per contract. There were 6422 open contracts at this strike prior to today, and today 135 contract(s) were bought and sold. 
• For HROW (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HROW#NASDAQ">HROW</a>), we notice a put option sweep that happens to be bullish, expiring in 413 day(s) on January 16, 2026. This event was a transfer of 19 contract(s) at a $50.00 strike. This particular put needed to be split into 11 different trades to become filled. The total cost received by the writing party (or parties) was $31.9K, with a price of $1680.0 per contract. There were 776 open contracts at this strike prior to today, and today 118 contract(s) were bought and sold. 
• For DHR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>), we notice a call option trade that happens to be bearish, expiring in 21 day(s) on December 20, 2024. This event was a transfer of 110 contract(s) at a $240.00 strike. The total cost received by the writing party (or parties) was $55.0K, with a price of $500.0 per contract. There were 491 open contracts at this strike prior to today, and today 114 contract(s) were bought and sold. 
• For PSTX (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSTX#NASDAQ">PSTX</a>), we notice a call option trade that happens to be bullish, expiring in 49 day(s) on January 17, 2025. This event was a transfer of 100 contract(s) at a $5.00 strike. The total cost received by the writing party (or parties) was $44.2K, with a price of $442.0 per contract. There were 85 open contracts at this strike prior to today, and today 110 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

APLT

GEHC

Hims & Hers Health, Inc. Class A Common Stock

HIMS

HROW

IBRX

PSTX

10 Health Care Stocks With Whale Alerts In Today's Session

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. 
Below are some instances of options activity happening in the Financials sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>BAC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$44.00</td>
<td>$69.6K</td>
<td>15.2K</td>
<td>1.3K</td>
</tr>
<tr>
<td>GS</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$300.00</td>
<td>$31.1K</td>
<td>569</td>
<td>952</td>
</tr>
<tr>
<td>JPM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$250.00</td>
<td>$58.5K</td>
<td>8.0K</td>
<td>841</td>
</tr>
<tr>
<td>C</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$70.00</td>
<td>$34.1K</td>
<td>52.2K</td>
<td>749</td>
</tr>
<tr>
<td>IBKR</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$195.00</td>
<td>$68.8K</td>
<td>353</td>
<td>424</td>
</tr>
<tr>
<td>ABR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$15.00</td>
<td>$31.6K</td>
<td>3.6K</td>
<td>227</td>
</tr>
<tr>
<td>TRV</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$250.00</td>
<td>$66.6K</td>
<td>440</td>
<td>129</td>
</tr>
<tr>
<td>CME</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$250.00</td>
<td>$26.6K</td>
<td>278</td>
<td>126</td>
</tr>
<tr>
<td>LMND</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$38.00</td>
<td>$38.4K</td>
<td>39</td>
<td>121</td>
</tr>
<tr>
<td>AFRM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$70.00</td>
<td>$29.1K</td>
<td>383</td>
<td>96</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These bullet-by-bullet explanations have been constructed using the accompanying table. 
• Regarding BAC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>), we observe a call option sweep with bearish sentiment. It expires in 49 day(s) on January 17, 2025. Parties traded 162 contract(s) at a $44.00 strike. This particular call needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $69.6K, with a price of $430.0 per contract. There were 15296 open contracts at this strike prior to today, and today 1320 contract(s) were bought and sold. 
• Regarding GS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>), we observe a call option trade with neutral sentiment. It expires in 49 day(s) on January 17, 2025. Parties traded 1 contract(s) at a $300.00 strike. The total cost received by the writing party (or parties) was $31.1K, with a price of $31187.0 per contract. There were 569 open contracts at this strike prior to today, and today 952 contract(s) were bought and sold. 
• Regarding JPM (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>), we observe a call option trade with bearish sentiment. It expires in 21 day(s) on December 20, 2024. Parties traded 100 contract(s) at a $250.00 strike. The total cost received by the writing party (or parties) was $58.5K, with a price of $585.0 per contract. There were 8043 open contracts at this strike prior to today, and today 841 contract(s) were bought and sold. 
• For C (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/C#NYSE">C</a>), we notice a call option sweep that happens to be bullish, expiring in 49 day(s) on January 17, 2025. This event was a transfer of 102 contract(s) at a $70.00 strike. This particular call needed to be split into 5 different trades to become filled. The total cost received by the writing party (or parties) was $34.1K, with a price of $335.0 per contract. There were 52204 open contracts at this strike prior to today, and today 749 contract(s) were bought and sold. 
• For IBKR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBKR#NASDAQ">IBKR</a>), we notice a call option trade that happens to be bearish, expiring in 21 day(s) on December 20, 2024. This event was a transfer of 200 contract(s) at a $195.00 strike. The total cost received by the writing party (or parties) was $68.8K, with a price of $344.0 per contract. There were 353 open contracts at this strike prior to today, and today 424 contract(s) were bought and sold. 
• For ABR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABR#NYSE">ABR</a>), we notice a put option sweep that happens to be bullish, expiring in 112 day(s) on March 21, 2025. This event was a transfer of 226 contract(s) at a $15.00 strike. This particular put needed to be split into 19 different trades to become filled. The total cost received by the writing party (or parties) was $31.6K, with a price of $140.0 per contract. There were 3648 open contracts at this strike prior to today, and today 227 contract(s) were bought and sold. 
• Regarding TRV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRV#NYSE">TRV</a>), we observe a call option trade with bullish sentiment. It expires in 21 day(s) on December 20, 2024. Parties traded 36 contract(s) at a $250.00 strike. The total cost received by the writing party (or parties) was $66.6K, with a price of $1850.0 per contract. There were 440 open contracts at this strike prior to today, and today 129 contract(s) were bought and sold. 
• For CME (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CME#NASDAQ">CME</a>), we notice a call option trade that happens to be bullish, expiring in 112 day(s) on March 21, 2025. This event was a transfer of 70 contract(s) at a $250.00 strike. The total cost received by the writing party (or parties) was $26.6K, with a price of $380.0 per contract. There were 278 open contracts at this strike prior to today, and today 126 contract(s) were bought and sold. 
• For LMND (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMND#NYSE">LMND</a>), we notice a put option sweep that happens to be bullish, expiring in 112 day(s) on March 21, 2025. This event was a transfer of 120 contract(s) at a $38.00 strike. This particular put needed to be split into 17 different trades to become filled. The total cost received by the writing party (or parties) was $38.4K, with a price of $320.0 per contract. There were 39 open contracts at this strike prior to today, and today 121 contract(s) were bought and sold. 
• For AFRM (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>), we notice a put option sweep that happens to be bullish, expiring in 21 day(s) on December 20, 2024. This event was a transfer of 60 contract(s) at a $70.00 strike. This particular put needed to be split into 11 different trades to become filled. The total cost received by the writing party (or parties) was $29.1K, with a price of $485.0 per contract. There were 383 open contracts at this strike prior to today, and today 96 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AFRM

IBKR

LMND

10 Financials Stocks Whale Activity In Today's Session

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. 
Here's the list of options activity happening in today's session: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NVDA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/29/24</td>
<td>$138.00</td>
<td>$69.8K</td>
<td>30.5K</td>
<td>167.2K</td>
</tr>
<tr>
<td>MU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/06/24</td>
<td>$98.00</td>
<td>$29.8K</td>
<td>832</td>
<td>14.2K</td>
</tr>
<tr>
<td>MARA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/06/24</td>
<td>$26.00</td>
<td>$71.9K</td>
<td>2.2K</td>
<td>7.9K</td>
</tr>
<tr>
<td>U</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$27.00</td>
<td>$41.0K</td>
<td>8.4K</td>
<td>6.0K</td>
</tr>
<tr>
<td>IREN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$18.00</td>
<td>$50.2K</td>
<td>0</td>
<td>5.9K</td>
</tr>
<tr>
<td>MSTR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>12/06/24</td>
<td>$400.00</td>
<td>$93.9K</td>
<td>3.4K</td>
<td>4.2K</td>
</tr>
<tr>
<td>AAPL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/29/24</td>
<td>$230.00</td>
<td>$89.9K</td>
<td>11.1K</td>
<td>3.8K</td>
</tr>
<tr>
<td>AMD</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/20/24</td>
<td>$135.00</td>
<td>$35.8K</td>
<td>5.1K</td>
<td>3.3K</td>
</tr>
<tr>
<td>BTDR</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>12/20/24</td>
<td>$15.00</td>
<td>$62.0K</td>
<td>7.7K</td>
<td>2.1K</td>
</tr>
<tr>
<td>CORZ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$20.00</td>
<td>$29.6K</td>
<td>27.0K</td>
<td>2.0K</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These bullet-by-bullet explanations have been constructed using the accompanying table. 
• For NVDA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), we notice a call option sweep that happens to be bullish, is expiring today. Parties traded 800 contract(s) at a $138.00 strike. This particular call needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $69.8K, with a price of $88.0 per contract. There were 30573 open contracts at this strike prior to today, and today 167213 contract(s) were bought and sold. 
• Regarding MU (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>), we observe a call option sweep with bullish sentiment. It expires in 7 day(s) on December 6, 2024. Parties traded 142 contract(s) at a $98.00 strike. This particular call needed to be split into 6 different trades to become filled. The total cost received by the writing party (or parties) was $29.8K, with a price of $209.0 per contract. There were 832 open contracts at this strike prior to today, and today 14236 contract(s) were bought and sold. 
• For MARA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MARA#NASDAQ">MARA</a>), we notice a put option sweep that happens to be bearish, expiring in 7 day(s) on December 6, 2024. This event was a transfer of 733 contract(s) at a $26.00 strike. This particular put needed to be split into 28 different trades to become filled. The total cost received by the writing party (or parties) was $71.9K, with a price of $98.0 per contract. There were 2261 open contracts at this strike prior to today, and today 7906 contract(s) were bought and sold. 
• Regarding U (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/U#NYSE">U</a>), we observe a call option sweep with bullish sentiment. It expires in 21 day(s) on December 20, 2024. Parties traded 672 contract(s) at a $27.00 strike. This particular call needed to be split into 10 different trades to become filled. The total cost received by the writing party (or parties) was $41.0K, with a price of $61.0 per contract. There were 8451 open contracts at this strike prior to today, and today 6016 contract(s) were bought and sold. 
• Regarding IREN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IREN#NASDAQ">IREN</a>), we observe a put option sweep with bearish sentiment. It expires in 168 day(s) on May 16, 2025. Parties traded 75 contract(s) at a $18.00 strike. This particular put needed to be split into 6 different trades to become filled. The total cost received by the writing party (or parties) was $50.2K, with a price of $670.0 per contract. There were 0 open contracts at this strike prior to today, and today 5971 contract(s) were bought and sold. 
• For MSTR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>), we notice a call option sweep that happens to be neutral, expiring in 7 day(s) on December 6, 2024. This event was a transfer of 32 contract(s) at a $400.00 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $93.9K, with a price of $2945.0 per contract. There were 3448 open contracts at this strike prior to today, and today 4266 contract(s) were bought and sold. 
• For AAPL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), we notice a call option sweep that happens to be bullish, is expiring today. Parties traded 139 contract(s) at a $230.00 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $89.9K, with a price of $647.0 per contract. There were 11175 open contracts at this strike prior to today, and today 3896 contract(s) were bought and sold. 
• Regarding AMD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>), we observe a call option sweep with bearish sentiment. It expires in 21 day(s) on December 20, 2024. Parties traded 56 contract(s) at a $135.00 strike. This particular call needed to be split into 17 different trades to become filled. The total cost received by the writing party (or parties) was $35.8K, with a price of $640.0 per contract. There were 5181 open contracts at this strike prior to today, and today 3301 contract(s) were bought and sold. 
• For BTDR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTDR#NASDAQ">BTDR</a>), we notice a call option sweep that happens to be bullish, expiring in 21 day(s) on December 20, 2024. This event was a transfer of 400 contract(s) at a $15.00 strike. This particular call needed to be split into 31 different trades to become filled. The total cost received by the writing party (or parties) was $62.0K, with a price of $155.0 per contract. There were 7715 open contracts at this strike prior to today, and today 2198 contract(s) were bought and sold. 
• For CORZ (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CORZ#NASDAQ">CORZ</a>), we notice a call option sweep that happens to be bullish, expiring in 413 day(s) on January 16, 2026. This event was a transfer of 57 contract(s) at a $20.00 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $29.6K, with a price of $520.0 per contract. There were 27048 open contracts at this strike prior to today, and today 2095 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AAPL

BTDR

Core Scientific, Inc. - Class A Common Stock

CORZ

IREN

MARA

MSTR

NVDA

10 Information Technology Stocks With Whale Alerts In Today's Session

Thermo Fisher Scientific's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TMO#NYSE">TMO</a>) short percent of float has risen 10.39% since its last report. The company recently reported that it has 3.23 million shares sold short, which is 0.85% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.99 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Thermo Fisher Scientific Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732901421_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Thermo Fisher Scientific has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Thermo Fisher Scientific's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Thermo Fisher Scientific's peer group average for short interest as a percentage of float is 4.79%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

How Is The Market Feeling About Thermo Fisher Scientific?

UiPath's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) short percent of float has risen 16.73% since its last report. The company recently reported that it has 27.20 million shares sold short, which is 6.42% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.39 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>UiPath Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732901415_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for UiPath has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing UiPath's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, UiPath's peer group average for short interest as a percentage of float is 5.05%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

PATH

(PATH) - Analyzing UiPath's Short Interest

Tenet Healthcare's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THC#NYSE">THC</a>) short percent of float has fallen 13.81% since its last report. The company recently reported that it has 2.08 million shares sold short, which is 2.87% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.49 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Tenet Healthcare Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732901410_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Tenet Healthcare has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Tenet Healthcare's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Tenet Healthcare's peer group average for short interest as a percentage of float is 4.10%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

(THC) - Analyzing Tenet Healthcare's Short Interest

The Yale Center for the Science of Cannabis and Cannabinoids, YC-SCAN², recently <a href="https://medicine.yale.edu/news-article/yale-center-for-the-science-of-cannabis-and-cannabinoids-announces-inaugural-pilot-award-winners/">announced</a> that it has awarded more than $600,000 in grants to 14 researchers from the Yale School of Medicine for innovative projects on the impact of <a href="https://www.benzinga.com/cannabis">cannabis</a> and <a href="https://www.benzinga.com/topic/cannabinoids">cannabinoids</a> on neurodevelopment and <a href="https://www.benzinga.com/topic/psychedelics-assisted-therapy">mental health</a>. These grants reflect YC-SCAN²'s ongoing commitment to advancing research in this rapidly evolving field.
Established in 2023, YC-SCAN² aims to be a leading hub for cannabis and cannabinoid science, conducting cutting-edge research while disseminating key findings to healthcare professionals and the public. Under the direction of Deepak Cyril D'Souza, MD, the center is focused on studying how cannabis affects the brain and overall health, particularly as <a href="https://www.benzinga.com/markets/cannabis/24/08/40121092/medical-cannabis-patients-increased-sixfold-in-six-years-declined-in-states-where-recreational-u">legal markets continue to grow</a> across the U.S.
"We received a highly competitive set of applications, making for a challenging selection process," said Dr. D'Souza. "The projects cover a broad range of topics, from the effects of cannabinoids on fetal and adolescent brain development, to the therapeutic potential of cannabinoids for pain and mental health disorders. We are optimistic that these projects will advance the science of cannabis and cannabinoids."
<h3 class="wp-block-heading">Key Research Areas</h3>
The awarded projects span a variety of important research topics, including the effects of cannabis on <a href="https://www.benzinga.com/markets/cannabis/24/07/39742388/cannabis-use-during-pregnancy-linked-to-child-brain-development-changes-study-finds">brain development</a> and its therapeutic potential for <a href="https://www.benzinga.com/markets/cannabis/23/10/34702634/does-recreational-cannabis-improve-mental-health-new-study-sheds-light">mental health conditions</a>. For example, Nicola Micali, PhD, will explore the impact of prenatal exposure to cannabinoids on primate brain development, which may shed light on similar effects in humans. Kristen Brennand, PhD, is studying how prenatal exposure to THC could increase the risk of psychiatric disorders later in life.
In pain management, Godfrey D. Pearlson, MD, is leading a study on the use of beta-caryophyllene, a cannabinoid, to treat chronic pain from reflex sympathetic dystrophy, a type of neuropathic pain. This project will investigate whether cannabinoids can offer an effective treatment for conditions that are typically resistant to traditional painkillers.
<h3 class="wp-block-heading">Cannabis And Mental Health</h3>
Many of the funded projects focus on the mental health implications of cannabis use, particularly its potential link to psychiatric conditions like schizophrenia and psychosis. Albert Powers, MD, PhD, and Jose Cortes-Briones, PhD, are investigating whether cannabis-induced brain states mimic the early stages of psychosis, providing crucial insights into cannabis's role in the development of mental health disorders.
Additionally, Mohini Ranganathan, MD, will evaluate the impact of cannabis use on schizophrenia risk using advanced neuroimaging techniques. This research will help clarify whether cannabis use increases the likelihood of developing psychotic disorders, especially in individuals with a genetic predisposition.
<h3 class="wp-block-heading">Looking To The Future Of Cannabis Research</h3>
YC-SCAN²'s commitment to funding this diverse research reflects the growing need for rigorous scientific studies into the effects of cannabis. Dr. D'Souza expressed confidence that these studies will contribute to a deeper understanding of cannabis and its potential therapeutic uses. &#8220;These projects are led by investigators at different stages of their careers and employ several novel approaches. We are hopeful that these studies will bring Yale to the forefront of cannabis research.&#8221;
The projects funded by YC-SCAN² will not only contribute to the scientific community but will also help educate healthcare professionals and the public about the complex role cannabis plays in human health. The research findings will be shared widely, with the goal of shaping both policy and medical practices related to cannabis use.
Cover image made with AI

Cannabis

Psychedelics

Yale Center Invests $600K+ On Cannabis Research Grants: These Are The Key Conditions Being Studied

Aptevo Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APVO#NASDAQ">APVO</a>) stock is trading lower Friday after the company announced a 1-for-37 reverse stock split.
The Details: The goal of the reverse stock split is to regain compliance with minimum bid price requirement of&nbsp;$1.00&nbsp;per share required to maintain continued listing on the Nasdaq.
Shares will begin trading on a split-adjusted basis on December 4 at market open. The reverse stock split will reduce the number of shares of the company&#8217;s outstanding common stock from approximately 18.5 million shares to 0.5 million shares.
It was approved by Aptevo&#8217;s shareholders at a special meeting held on Oct. 25, 2024.
How To Buy Aptevo Shares
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in Aptevo Therapeutics's case, it is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
APVO Price Action: At the time of writing Aptevo shares are trading 18.9% lower at 28 cents, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: 6368031 from Pixabay.

Movers

APVO

What's Going On With Aptevo Therapeutics Shares Friday?

Some consumers might have groceries on their minds instead of Christmas gifts or in their<a href="https://www.benzinga.com/topic/black-friday"> holiday shopping carts.</a>
What Happened: Consumers are looking for top deals on televisions, video game consoles and toys this Black Friday shopping season, which comes as experts predict the shopping holiday <a href="https://www.benzinga.com/news/24/11/42236796/black-friday-cyber-monday-shopping-set-to-break-sales-records">could top records</a>.
Data from <a href="https://www.similarweb.com/">Similarweb</a>, which tracks Amazon, Best Buy, Target and Walmart shows that televisions, laptops, Legos and Apple products are among the items being searched for the most on Black Friday.
Consumers searching for items on Walmart's Inc.&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) website might have other plans with grocery items thrown into the mix.
Here are the top 10 searched-for items on Walmart's website on Black Friday according to early data.
<ol>
<li>TV</li>
<li>Lego</li>
<li>Eggs</li>
<li>Milk</li>
<li>Bread</li>
<li>Slippers</li>
<li>Pokemon Cards</li>
<li>Pokemon</li>
<li>PS5</li>
<li>iPhone</li>
</ol>
Televisions being the top-searched item isn't a huge surprise as the electronics item is often a top Black Friday sale item and heavy discounts can lead to consumers waiting until the shopping day to make the big purchase.
What comes as more of a surprise are eggs, milk and bread, as well as slippers, among the most-searched items on Black Friday.
Read Also: <a href="https://www.benzinga.com/24/11/42247063/apple-products-dominate-early-black-friday-trending-searches">Apple Products Dominate Early Black Friday Trending Searches</a>
Why It's Important: The search results don't mean Walmart is offering doorbuster sales on eggs, milk or bread.
Instead this likely means consumers are buying groceries on Black Friday or adding regular shopping items to their carts as they shop for other products.
The price of eggs rose in recent weeks ahead of the busy holiday baking season due to fears of<a href="https://www.benzinga.com/general/biotech/24/11/42197195/bird-flu-found-in-raw-milk-leads-to-recall-in-california"> increased avian flu outbreaks.</a>
While <a href="https://www.benzinga.com/topic/inflation">concerns of inflation</a> have eased in recent months, bread, milk and eggs being among the most-searched items on Black Friday could show fears that consumers are still struggling with higher grocery prices.
WMT Price Action: Walmart stock trades at $92.48 on Friday, after hitting a new 52-week high earlier in the trading session. Walmart stock is up 73% year-to-date in 2024.
Photo: Shutterstock

Walmart Shoppers Shun Electronics For Black Friday Deals On Eggs, Bread, Slippers

Ayurcann Holdings Corp. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/AYUR#CSE">AYUR</a>) (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/AYURF#OTCQB">AYURF</a>), a Canadian processing and manufacturing company specializing in cannabis 2.0 and 3.0 products, announced on Thursday its first quarter financial and operational results for the three months ended Sept. 30, 2024.
The Toronto-based company highlighted a 25% year-over-year increase in gross revenue, strong gross margin and top market presence in the vapes and pre-roll category in Ontario during the period.
Ayurcann noted that fiscal 2024 and the beginning of fiscal 2025 was a pivotal time for the company and the broader cannabis industry in Canada. CEO Igal Sudman said the company's business model and disciplined execution have allowed Ayurcann to expand across all levels.
<ul>
<li>Get Benzinga's exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.</li>
</ul>
"By focusing on innovation, building strong partnerships, and growing our signature brands—such as Fuego, Xplor, Xplor LevelX and Happy &amp; Stoned—we continue to deliver consistent quarter-over-quarter growth,&#8221; Sudman said. &#8220;Our vision remains clear: to become a dominant player in the cannabis industry.&#8221; 
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/10/41599674/marijuana-extraction-company-ayurcann-reports-record-gross-revenue-for-fiscal-year-2024">Marijuana Extraction Company Ayurcann Reports Record Gross Revenue For Fiscal Year 2024</a>
<h3 class="wp-block-heading">Q1 2025 Financial Highlights</h3>
<ul>
<li>After deducting agency and service fees (CA$102,783) and excise duties (CA$6.35 million), net revenue stood at CA$8.3 million, an increase from CA$6.5 million in the prior year's period, representing a 28% increase year-over-year.</li>
<li>Expenses amounted to CA$3.3 million, up from CA$2.3 million in the same quarter of 2023.</li>
<li>Net loss and comprehensive loss was CA$356,711, compared to roughly CA$209,000.</li>
<li>Cash at the end of the period was CA$891,783, down from CA$1.5 million in the prior year's period.</li>
</ul>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/03/37924655/canadian-cannabis-companies-could-see-valuations-soar-by-up-to-300-with-tax-reform-">Canadian Cannabis Companies Could See Valuations Soar By Up To 300% With Tax Reform, New Report Shows</a></li>
</ul>

Earnings

AYURF

CSE:AYUR

Ayurcann Cannabis Co. Reports 28% YoY Net Revenue Growth In Q1 With Strong Performance In Vapes And Pre-Rolls

PJT Partners's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PJT#NYSE">PJT</a>) short percent of float has risen 8.37% since its last report. The company recently reported that it has 1.36 million shares sold short, which is 7.77% of all regular shares that are available for trading. Based on its trading volume, it would take traders 5.5 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>PJT Partners Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732900524_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for PJT Partners has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing PJT Partners's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, PJT Partners's peer group average for short interest as a percentage of float is 2.75%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About PJT Partners?

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Axsome Therapeutics (AXSM – Research Report), Madrig...

Analysts Are Bullish on Top Healthcare Stocks: Axsome Therapeutics (AXSM), Madrigal Pharmaceuticals (MDGL)

Applied Therapeutics: FDA Denial Of Govorestat NDA As Problematic As It Was Unexpected

RBC Capital analyst Brian Abrahams downgraded Applied Therapeutics (APLT) to Sector Perform from Outperform with a price target of $4, down from $1...

Applied Therapeutics downgraded to Sector Perform from Outperform at RBC

William Blair says Applied Therapeutics (APLT)' complete response letter from the FDA for govorestat for the treatment of galactosemia is "unexpect...

Applied Therapeutics CRL a 'major setback,' says William Blair

Check out this morning's top movers from around Wall Street, compiled by The Fly.&nbsp; HIGHER – Voyager Therapeutics (VYGR) up 7% after Wedbush up...

Voyager rises after upgrade, Applied plunges after CRL: Morning Movers

Applied Therapeutics stock craters 75% on FDA setback

Baird analyst Brian Skorney lowered the firm's price target on Applied Therapeutics (APLT) to $5 from $14 and keeps an Outperform rating on the sha...

Applied Therapeutics price target lowered to $5 from $14 at Baird

Unusual total active option classes on open include: Kellogg (K), Outlook Therapeutics Inc (OTLK), Regions Financial (RF), Applied Therapeutics (AP...

Unusually active option classes on open November 29th

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need...

Voyager upgraded, HP downgraded: Wall Street's top analyst calls

Citi analyst Yigal Nochomovitz lowered the firm's price target on Applied Therapeutics (APLT) to $8 from $13 and keeps a Buy rating on the shares, ...

Applied Therapeutics target lowered to $8, 'catalyst watch' removed at Citi

ADSK

AXSM

DELL

MDGL

OTLK

RMBL

SOXS

VYGR

Management

Press Releases

Applied Therapeutics Appoints Dale Hooks as Chief Commercial Officer

Applied Therapeutics to Present at the 2024 RBC Capital Markets Global Healthcare Conference

Applied Therapeutics Reports First Quarter 2024 Financial Results

Applied Therapeutics Added to Russell 3000® Index

Applied Therapeutics Reports Second Quarter 2024 Financial Results

Applied Therapeutics to Participate in Upcoming Investor Conferences

Applied Therapeutics Provides Regulatory Update on Govorestat for the Treatment of Classic Galactosemia

Applied Therapeutics to Present at the 2024 UBS Global Healthcare Conference

Applied Therapeutics Reports Third Quarter 2024 Financial Results

Applied Therapeutics Receives Complete Response Letter from U.S. FDA Regarding New Drug Application for Govorestat for Classic Galactosemia

Autolus Therapeutics plc - American Depositary Shares

Autolus Therapeutics

ArriVent BioPharma

Bicara Therapeutics

Capricor Therapeutics, Inc. - Common Stock

Capricor Therapeutics

Avid Bioservices

CareDx

Cogent Biosciences

Cargo Therapeutics

Erasca

89bio

Gyre Therapeutics

Immunome

Immatics

Kura Oncology

LENZ Therapeutics

Mesoblast Limited - American Depositary Shares

Mesoblast

Prothena Corporation plc - Ordinary Shares

Prothena Corp

Poseida Therapeutics, Inc. - Common Stock

Poseida Therapeutics

Rocket Pharmaceuticals, Inc. - Common Stock

Rocket Pharmaceuticals

Replimune Group

Relay Therapeutics

Tyra Biosciences

Upstream Bio

Vir Biotechnology

Zymeworks

RBC Capital

Citigroup

Leerink Partners

Baird

Applied Therapeutics shares are trading lower after the company announced the FDA highlighted deficiencies in a clinical application for a lead program

Comments

Applied Therapeutics

Intérêt court

Applied Therapeutics (NASDAQ:APLT) Stock, Rapport sur les intérêts à découvert

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL